Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): NIOSH Occupational Safety and Health Project Grants, Program Announcement Number (PAR) 06-484, 9342 [E7-3653]
Download as PDF
<![CDATA[
9342
Federal Register / Vol. 72, No. 40 / Thursday, March 1, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Food and Drug Administration
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): NIOSH
Occupational Safety and Health Project
Grants, Program Announcement
Number (PAR) 06–484
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
rmajette on PROD1PC67 with NOTICES
Time and Date: 8:30 a.m.–5:30 p.m., March
15, 2007 (Closed).
Place: Residence Inn, 1456 Duke Street,
Alexandria, VA 22314, telephone 703–548–
5474.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The SEP meeting
will include the review, discussion, and
evaluation of applications received in
response to ‘‘NIOSH Occupational Safety and
Health Project Grants,’’ PAR 06–484. The
applications being reviewed include
information of a confidential nature,
including personal information concerning
individuals associated with the applications.
This Federal Register Notice is being
published on less than 15 calendar days
notice to the public (41 CFR 102–3.150(b)),
for the following reason: The cancellation of
a preparatory meeting scheduled for January
16th due to inclement weather caused the
late publication of this notice. Convening the
preparatory meeting was necessary before
this meeting could be scheduled. The
preparatory meeting occurred on February
20–21, 2007, which enabled the program to
finalize plans for this meeting.
For Further Information Contact:Charles
Rafferty, Ph.D., Designated Federal Officer,
1600 Clifton Road NE, Atlanta, GA 30333,
telephone 404–498–2582.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–3653 Filed 2–28–07; 8:45 am]
BILLING CODE 4163–18–P
VerDate Aug<31>2005
15:01 Feb 28, 2007
Jkt 211001
The Essentials of Food and Drug
Administration Medical Device
Regulations: A Primer for
Manufacturers and Suppliers; Public
Seminar
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public seminar.
SUMMARY: The Food and Drug
Administration’s (FDA’s) Center for
Devices and Radiological Health and
Office of Regulatory Affairs, in
cooperation with AdvaMed’s Medical
Technology Learning Institute, is
announcing a series of three seminars
on FDA medical device regulations.
These 2-day seminars, which are
designed to address the training needs
of start up and small device
manufacturers and their suppliers, will
include both industry and FDA
perspectives and a question and answer
period.
Dates: The seminars are planned for
the following dates:
1. March 15 and 16, 2007, in Irvine,
CA 92614. Details about dates are
posted on AdvaMed’s Web site at:
www.advamed.org/irvine.1
2. May 22 and 23, 2007, in Lakewood,
CO 80228. Details about dates are
posted on AdvaMed’s Web site at:
www.advamed.org/denver.
3. June 6 and 7, 2007, in Pittsburgh,
PA, Details about dates are posted on
AdvaMed’s Web site at:
www.advamed.org/pittsburgh.
Locations: The seminars are planned
for the following locations:
1. March 15 and 16, 2007, Crown
Plaza Hotel, 17941 Von Karman, Irvine,
CA 92614. Details about location sites
are posted on AdvaMed’s Web site at:
www.advamed.org/irvine.
2. May 22 and 23, 2007, Sheraton
Denver West, 360 Union Blvd.,
Lakewood, CO 80228. Details about
location sites are posted on AdvaMed’s
Web site at: www.advamed.org/denver.
3. June 6 and 7, 2007, Hilton
Pittsburgh, 600 Commonwealth Pl.,
Pittsburgh, PA 15222,
www.HiltonPittsburgh.com. Details
about location sites are posted on
AdvaMed’s Web site at:
www.advamed.org/pittsburgh.
Contact: For FDA: William Sutton,
Division of Small Manufacturers,
1 FDA has verified the Web site addresses, but
FDA is not responsible for any subsequent changes
to the Web sites after this document publishes in
the Federal Register.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
International and Consumer Assistance,
Center for Devices and Radiological
Health (HFZ–220), 1350 Piccard Dr.,
Rockville, MD 20850, 800–638–2041,
ext. 125, FAX: 240–276–3151, e-mail:
William.sutton@fda.hhs.gov.
For AdvaMed: Dia Black, 202–434–
7231, FAX: 202–783–8750, e-mail:
DBlack@AdvaMed.org.
Registration: The registration fee for
FDA employees is waived. Send
registration information (including
name, title, firm name, address,
telephone, and fax number) and the
registration fee of $495 per person to
AdvaMed contact Dia Black, 202–434–
7231, FAX: 202–783–8750. Payment
forms accepted are major credit card
(MasterCard, Visa, or American Express)
or company check. If you wish to pay
by check, contact Dia Black at:
DBlack@AdvaMed.org.
To register via the Internet, go to
www.AdvaMed.org. The latest
information on dates/venue sites will be
posted on this Web site at:
www.advamed.org/irvine,
www.advamed.org/denver, and
www.advamed.org/pittsburgh (FDA has
verified the Web site addresses, but is
not responsible for changes to the Web
sites after this document publishes in
the Federal Register).
For more information on the meeting,
or for questions on registration, contact
Dia Black (see Contact).
Attendees are responsible for their
own accommodations. For further hotel
information and driving directions, go
to the registration Web site.
The registration fee will be used to
offset the expenses of hosting the
conference, including meals (breakfasts
and a lunch), refreshments, meeting
rooms, and training materials. It also
includes a networking reception on the
evening of the first day of each seminar.
Space is limited; therefore, interested
parties are encouraged to register early.
There will be no onsite registration.
If you need special accommodations
due to a disability, please contact Dia
Black (see Contact) at AdvaMed at least
7 days in advance of the seminar.
SUPPLEMENTARY INFORMATION: The
‘‘Essentials of FDA Medical Device
Regulations: A Primer for Manufacturers
and Suppliers’’ seminar helps fulfill the
Department of Health and Human
Services’ and FDA’s important mission
to protect the public health by educating
new entrepreneurs on the essentials of
FDA device regulations. FDA has made
education of the medical device
community a high priority to assure the
quality of products reaching the
marketplace and to increase the rate of
voluntary industry compliance with
regulations.
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 72, Number 40 (Thursday, March 1, 2007)]
[Notices]
[Page 9342]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3653]
[[Page 9342]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): NIOSH Occupational Safety and Health Project
Grants, Program Announcement Number (PAR) 06-484
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 8:30 a.m.-5:30 p.m., March 15, 2007 (Closed).
Place: Residence Inn, 1456 Duke Street, Alexandria, VA 22314,
telephone 703-548-5474.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The SEP meeting will include the
review, discussion, and evaluation of applications received in
response to ``NIOSH Occupational Safety and Health Project Grants,''
PAR 06-484. The applications being reviewed include information of a
confidential nature, including personal information concerning
individuals associated with the applications.
This Federal Register Notice is being published on less than 15
calendar days notice to the public (41 CFR 102-3.150(b)), for the
following reason: The cancellation of a preparatory meeting
scheduled for January 16th due to inclement weather caused the late
publication of this notice. Convening the preparatory meeting was
necessary before this meeting could be scheduled. The preparatory
meeting occurred on February 20-21, 2007, which enabled the program
to finalize plans for this meeting.
For Further Information Contact:Charles Rafferty, Ph.D.,
Designated Federal Officer, 1600 Clifton Road NE, Atlanta, GA 30333,
telephone 404-498-2582.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: February 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-3653 Filed 2-28-07; 8:45 am]
BILLING CODE 4163-18-P
